The Russian Sputnik V COVID-19 vaccine is 91.6% effective, according to an interim analysis of a late-stage, phase 3 clinical trial.
Published on Tuesday by the British medical journal Lancet, the analysis found the Sputnik V vaccine is safe and effective, with no reports of serious adverse side effects.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.